Judit Meszaros Jørgensen (Judit Jørgensen)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Cardiovascular Risk Factors

Diffuse Large B Cell Lymphoma

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmed Ludvigsen Al-Mashhadi, Lasse Hjort Kyneb Jakobsen, Peter de Nully Brown, Anne Ortved Gang, Anne-Luise Thorsteinsson, Kaziwa Rasoul, Judith Melchior Haissman, Michael Buch Tøstesen, Mette Niemann Christoffersen, Jelena Jelicic, Jennifer Bøgh Jørgensen, Troels Thomsen, Andriette Dessau-Arp, Andreas P H Andersen, Mikael Frederiksen, Per Trøllund Pedersen, Michael Roost Clausen, Judit Meszaros Jørgensen, Christian Bjørn Poulsen, Tarec Christoffer El-Galaly, Thomas Stauffer Larsen
Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas. British journal of haematology (2023)
Leo Meriranta, Amjad Alkodsi, Annika Pasanen, Maija Lepistö, Parisa Mapar, Yngvild Nuvin Blaker, Judit Meszaros Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Idun Fiskvik, Lars Tore G Mikalsen, Matias Autio, Magnus Björkholm, Mats Jerkeman, Øystein Fluge, Peter de Nully Brown, Sirkku Jyrkkiö, Harald Holte, Esa Pitkänen, Pekka Ellonen, Sirpa Leppa
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma. Blood 139 (12) (2022)
Heli Vajavaara, Suvi-Katri Leivonen, Judit Meszaros Jørgensen, Harald Holte, Sirpa Leppa
Low lymphocyte-to-monocyte ratio predicts poor outcome in high-risk aggressive large B-cell lymphoma. EJHaem 3 (3) (2022)
Joachim Bæch, Marianne Tang Severinsen, Andreas K Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit Meszaros Jørgensen, Michael Roost Clausen, Christian B Poulsen, Peter de Nully Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin Ekström Smedby, Sandra Eloranta, Lasse Hjort Jakobsen, Tarec Christoffer El-Galaly
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy. Blood advances 6 (15) (2022)